Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T17:03:49.007Z.
Calculation as of: 2026-10-06T17:03:49.007Z.
Quote observation: 2026-10-06T16:53:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d2e468d5d1fee912cc594a855ce64a44190db3c5d14d549897f680d6209c50fe
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-05-15.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Precision Optics Corporation, Inc.
Market Cap
$47.83M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.23M
EV/EBITDA Ratio
N/A
TTM Avg
10.84x
3Y Avg
9.14x
5Y Avg
10.29x
Market Cap
$50.13M
EV/EBITDA Ratio
N/A
TTM Avg
310.55x
3Y Avg
191.07x
5Y Avg
171.86x
Market Cap
$50.25M
EV/EBITDA Ratio
N/A
TTM Avg
35309.82x
3Y Avg
79402.66x
5Y Avg
79402.66x
Market Cap
$45.37M
EV/EBITDA Ratio
N/A
TTM Avg
14.42x
3Y Avg
17.44x
5Y Avg
22.72x
Market Cap
$45.20M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision Optics Corporation, Inc. (POCI) | $47.83M | N/A | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.23M | N/A | 10.84x | 9.14x | 10.29x |
| Lite Strategy, Inc. (LITS)vs › | $48.66M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.13M | N/A | 310.55x | 191.07x | 171.86x |
| INmune Bio, Inc. (INMB)vs › | $50.25M | N/A | 35309.82x | 79402.66x | 79402.66x |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | 14.42x | 17.44x | 22.72x |
| Apollomics, Inc. (APLM)vs › | $50.18M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $50.54M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $50.80M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2023-05-15 | 118.37x |
| 2023-05-12 | 111.51x |
| 2023-05-11 | 112.69x |
| 2023-05-10 | 113.22x |
| 2023-05-09 | 110.99x |
| 2023-05-08 | 110.99x |
| 2023-05-05 | 116.14x |
| 2023-05-04 | 112.36x |
| 2023-05-03 | 114.08x |
| 2023-05-02 | 112.36x |
| 2023-05-01 | 113.22x |
| 2023-04-28 | 114.93x |
| 2023-04-27 | 115.79x |
| 2023-04-26 | 114.30x |
| 2023-04-25 | 116.31x |
| 2023-04-24 | 116.65x |
| 2023-04-21 | 116.65x |
| 2023-04-20 | 119.23x |
| 2023-04-19 | 119.60x |
| 2023-04-18 | 118.92x |
| 2023-04-17 | 120.43x |
| 2023-04-14 | 119.23x |
| 2023-04-13 | 114.94x |
| 2023-04-12 | 114.08x |
| 2023-04-11 | 121.12x |
| 2023-04-10 | 121.12x |
| 2023-04-06 | 122.49x |
| 2023-04-05 | 123.35x |
| 2023-04-04 | 116.14x |
| 2023-04-03 | 116.65x |
| 2023-03-31 | 123.35x |
| 2023-03-30 | 116.82x |
| 2023-03-29 | 117.68x |
| 2023-03-28 | 110.99x |
| 2023-03-27 | 109.78x |
| 2023-03-24 | 109.78x |
| 2023-03-23 | 111.33x |
| 2023-03-22 | 111.33x |
| 2023-03-21 | 111.50x |
| 2023-03-20 | 110.99x |
| 2023-03-17 | 107.72x |
| 2023-03-16 | 122.32x |
| 2023-03-15 | 121.12x |
| 2023-03-14 | 130.22x |
| 2023-03-13 | 122.03x |
| 2023-03-10 | 118.88x |
| 2023-03-09 | 123.52x |
| 2023-03-08 | 129.27x |
| 2023-03-07 | 130.22x |
| 2023-03-06 | 129.19x |
| 2023-03-03 | 130.39x |
| 2023-03-02 | 129.53x |
| 2023-03-01 | 128.16x |
| 2023-02-28 | 127.81x |
| 2023-02-27 | 128.16x |
| 2023-02-24 | 127.30x |
| 2023-02-23 | 126.95x |
| 2023-02-22 | 126.95x |
| 2023-02-21 | 126.95x |
| 2023-02-17 | 126.78x |
| 2023-02-16 | 126.95x |
| 2023-02-15 | 126.01x |
